Sancode Technologies IPO vs Sotac Pharmaceuticals IPO

Comparision between Sancode Technologies IPO and Sotac Pharmaceuticals IPO.

IPO Details

Sancode Technologies IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Sotac Pharmaceuticals IPO is a SME Book Built Issue proposed to list at NSE SME.

	Sancode Technologies IPO	Sotac Pharmaceuticals IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Fixed Price Issue	Book Built Issue
Listing At	BSE SME	NSE SME
Lead Managers	Shreni Shares Limited	Beeline Capital Advisors Pvt Ltd
Registrar	Bigshare Services Pvt Ltd	Kfin Technologies Limited
Market Maker	Shreni Shares Limited	Sunflower Broking Private Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor		Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Sancode Technologies IPO is up to ₹5.15 Cr whereas the issue size of the Sotac Pharmaceuticals IPO is up to ₹33.30 Cr. The final issue price of Sancode Technologies IPO is ₹47.00 per share and of Sotac Pharmaceuticals IPO is ₹111.00 per share.

	Sancode Technologies IPO	Sotac Pharmaceuticals IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)		₹105.00 per share
Issue Price (Upper)		₹111.00 per share
Issue Price (Final)	₹47.00 per share	₹111.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	3000 shares	1200 shares
Fresh Issue Size	10,95,000 shares	30,00,000 shares
Fresh Issue Size (Amount)	up to ₹5.15 Cr	up to ₹33.30 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	10,95,000 shares	30,00,000 shares
Issue Size Total (Amount)	up to ₹5.15 Cr	up to ₹33.30 Cr

IPO Timetable

Sancode Technologies IPO opens on Mar 31, 2023, while Sotac Pharmaceuticals IPO opens on Mar 29, 2023. The closing date of Sancode Technologies IPO and Sotac Pharmaceuticals IPO is Apr 06, 2023, and Apr 03, 2023, respectively.

	Sancode Technologies IPO	Sotac Pharmaceuticals IPO
Anchor Bid Date		Mar 28, 2023
Issue Open	Mar 31, 2023	Mar 29, 2023
Issue Close	Apr 06, 2023	Apr 03, 2023
Basis Of Allotment (Tentative)	Apr 12, 2023	Apr 10, 2023
Initiation of Refunds (Tentative)	Apr 13, 2023	Apr 11, 2023
Credit of Share (Tentative)	Apr 17, 2023	Apr 12, 2023
Listing date (Tentative)	Apr 18, 2023	Apr 13, 2023
Anchor Lockin End date 1	May 12, 2023	May 10, 2023
Anchor Lockin End date 2	Jul 11, 2023	Jul 09, 2023

Financials

Sancode Technologies IPO P/E ratio is 10.71, as compared to Sotac Pharmaceuticals IPO P/E ratio of 132.14.

Sancode Technologies IPO

Sotac Pharmaceuticals IPO

Financial

Sancode Technologies Limited Financial Information (Restated Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-20	330.45	43.08	-112.98	220.83	197.95	0.22
31-Mar-21	313.96	159.74	-26.17	223.56	200.69	63.73
31-Mar-22	349.87	244.81	75.12	287.07	264.19	20.76
30-Sep-22	481.26	180.62	89.36	367.54	344.67	21.20
Amount in ₹ Lakhs

Sotac Pharmaceuticals Limited Financial Information (Restated Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-20	3,038.21	2,882.64	8.75	305.73	75.73	15.13
31-Mar-21	3,469.75	4,894.97	-236.54	249.36	19.36	1,035.80
31-Mar-22	3,525.35	7,337.02	287.86	662.19	432.19	1,134.59
30-Sep-22	6,461.60	3,994.65	46.55	797.41	567.41	2,185.52
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

97.47%

84.63%

Promoter Shareholding (Post-Issue)

71.24%

P/E Ratio

10.71

132.14

Market Cap

₹19.12 Cr.

₹122.66 Cr.

ROE

6.38%%

ROCE

19.03%%

Debt/Equity

2.74

EPS

RoNW

Shares Offered

In the Sancode Technologies IPO retail investors (RII) are offered 5,19,000 shares while in Sotac Pharmaceuticals IPO retail investors are offered 5,19,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in Sancode Technologies IPO and 5,71,800 shares in Sotac Pharmaceuticals IPO.

	Sancode Technologies IPO	Sotac Pharmaceuticals IPO
Anchor Investor Reserveration		8,53,200 shares
Market Maker Reserveration	57,000 shares	1,50,000 shares
QIB	0 shares	5,71,800 shares
NII	5,19,000 shares	4,28,400 shares
RII	5,19,000 shares	9,98,400 shares
Employee	0 shares	0 shares
Others
Total	10,38,000 shares	19,98,600 shares

Bids Received (Subscription)

Sancode Technologies IPO subscribed 3.68x in total, whereas Sotac Pharmaceuticals IPO subscribed 1.60x.

	Sancode Technologies IPO	Sotac Pharmaceuticals IPO
QIB (times)		1.00x
NII (times)	3.98x	4.04x
Big NII (times)
Small NII (times)
RII (times)	3.39x	0.91x
Employee (times)
Other (times)
Total (times)	3.68x	1.60x

Compare with others

Sancode Technologies IPO	Sotac Pharmaceuticals IPO
De Neers Tools IPO	Retina Paints IPO
Quicktouch Technologies IPO	A G Universal IPO
Retina Paints IPO	Pattech Fitwell Tube Components IPO
A G Universal IPO	Sancode Technologies IPO
Pattech Fitwell Tube Components IPO	Exhicon Events IPO
Exhicon Events IPO	MOS Utility IPO
Sotac Pharmaceuticals IPO	Infinium Pharmachem IPO
MOS Utility IPO	Maiden Forgings IPO
Infinium Pharmachem IPO	Command Polymers IPO
Maiden Forgings IPO	Dev Labtech Venture IPO

Comments

Add a public comment...